LATe TreatmENT Related Toxicity in Melanoma (LATENT)

Not yet recruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Melanoma

Interventions

OTHER

Observational - no intervention

Trial Locations (1)

Royal Marsden NHS Foundation Trust, Chelsea

All Listed Sponsors

lead

Royal Marsden NHS Foundation Trust

OTHER

NCT06414343 - LATe TreatmENT Related Toxicity in Melanoma (LATENT) | Biotech Hunter | Biotech Hunter